Bennett Melanie E, Bellack Alan S, Gearon Jean S
Department of Psychiatry, University of Maryland School of Medicine, 737 West Lombard Street, Suite 551, Baltimore, Maryland, 21201, USA.
Addict Behav. 2006 Dec;31(12):2249-67. doi: 10.1016/j.addbeh.2006.03.012. Epub 2006 May 5.
This paper provides a description of The Substance Use Event Survey for Severe Mental Illness (SUESS), a brief (20-30 min) interview that assesses clinical issues and domains that are relevant patients with substance use disorders and severe mental illness. First, we discuss the need for a new clinical measure for dual diagnosis patients, as well as our process of creating domains and items and developing the content of the assessment. Second, we provide a first look at the performance of the SUESS in a large sample of dually diagnosed patients from several large scale studies, including how patients responded to the instrument and their ability to complete the items. Third, we present initial reliability data on the SUESS. Finally, we include some initial validity data, including comparison of the self-report of substance use questions to urinalysis results, and verification of the service use information from medical record review. The SUESS appears to be a useful assessment that is tolerated and understood by dual diagnosis patients, and shows good preliminary reliability and validity.
本文介绍了严重精神疾病物质使用事件调查（SUESS），这是一项简短（20 - 30分钟）的访谈，用于评估与患有物质使用障碍和严重精神疾病的患者相关的临床问题和领域。首先，我们讨论了针对双重诊断患者制定新临床测量方法的必要性，以及我们创建领域和项目并开发评估内容的过程。其次，我们首次展示了SUESS在来自多项大规模研究的大量双重诊断患者样本中的表现，包括患者对该工具的反应以及他们完成项目的能力。第三，我们呈现了SUESS的初始信度数据。最后，我们纳入了一些初始效度数据，包括物质使用问题的自我报告与尿液分析结果的比较，以及通过病历审查对服务使用信息的核实。SUESS似乎是一种有用的评估工具，双重诊断患者能够接受并理解它，并且显示出良好的初步信度和效度。
